STOCK TITAN

[Form 4] Ulta Beauty, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Stephanie Lee Landry, a director of Ulta Beauty, Inc. (ULTA), acquired 277 restricted stock units on 09/01/2025. The Form 4 reports the grant as an acquisition (code A) at no cash price ($0). The filing shows 277 shares beneficially owned following the transaction in a direct ownership form. The RSUs are described in the explanation as vesting 100% on 09/01/2026. The Form 4 was signed by an attorney-in-fact on 09/03/2025. No derivatives, option exercises, cash purchases, or sales are reported in this filing.

Stephanie Lee Landry, membro del consiglio di Ulta Beauty, Inc. (ULTA), ha acquisito 277 unità azionarie vincolate il 01/09/2025. Il Modulo 4 riporta la concessione come acquisizione (codice A) senza pagamento in contanti ($0). La dichiarazione indica la detenzione beneficiaria di 277 azioni a seguito della transazione in forma di proprietà diretta. Le RSU sono descritte nell’esplicazione come soggette a vesting al 100% il 01/09/2026. Il Modulo 4 è stato firmato da un procuratore il 03/09/2025. Non risultano derivati, esercizi di opzioni, acquisti in contanti o vendite in questa comunicazione.

Stephanie Lee Landry, directora de Ulta Beauty, Inc. (ULTA), adquirió 277 unidades restringidas de acciones el 01/09/2025. El Formulario 4 reporta la concesión como una adquisición (código A) sin pago en efectivo ($0). La presentación muestra 277 acciones en propiedad beneficiaria tras la transacción en forma de titularidad directa. Las RSU se describen en la explicación como sujetas a vesting al 100% el 01/09/2026. El Formulario 4 fue firmado por un apoderado el 03/09/2025. No se informan derivados, ejercicios de opciones, compras en efectivo ni ventas en esta presentación.

Ulta Beauty, Inc.(ULTA) 이사인 스테파니 리 랜드리(Stephanie Lee Landry)가 2025-09-01에 제한부주식단위(RSU) 277주를 취득했습니다. Form 4는 해당 부여를 현금 대가 없는 취득(코드 A)으로 보고하고 있습니다($0). 제출서류에는 거래 후 직접 소유 형태로 277주를 실질적으로 보유하고 있는 것으로 표시되어 있습니다. RSU는 설명란에 2026-09-01에 100% 베스팅된다고 기재되어 있습니다. Form 4는 2025-09-03에 대리인(변호사 대리인)에 의해 서명되었습니다. 이 제출에는 파생상품, 옵션 행사, 현금 매수 또는 매도는 보고되지 않았습니다.

Stephanie Lee Landry, administratrice d’Ulta Beauty, Inc. (ULTA), a acquis 277 unités d’actions restreintes le 01/09/2025. Le formulaire 4 signale la remise comme une acquisition (code A) sans contrepartie en espèces (0 $). Le dépôt indique 277 actions détenues bénéficiairement après la transaction sous une forme de propriété directe. Les RSU sont décrites dans l’explication comme vestant à 100 % le 01/09/2026. Le formulaire 4 a été signé par un mandataire le 03/09/2025. Aucun dérivé, exercice d’option, achat en espèces ou vente n’est déclaré dans ce dépôt.

Stephanie Lee Landry, Direktorin von Ulta Beauty, Inc. (ULTA), erwarb am 01.09.2025 277 Restricted Stock Units. Das Formular 4 meldet die Zuteilung als Erwerb (Code A) ohne Barzahlung ($0). Die Einreichung weist nach der Transaktion 277 wirtschaftlich gehaltene Aktien in direktem Eigentum aus. In der Erläuterung werden die RSUs mit vollständiger Vesting zum 01.09.2026 beschrieben. Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten unterzeichnet. In dieser Meldung sind keine Derivate, Optionsausübungen, Barkäufe oder Verkäufe angegeben.

Positive
  • Alignment of interests: 277 restricted stock units vesting in one year align the director's incentives with shareholders.
  • No cash outlay required: The grant is recorded at $0, indicating standard compensation rather than a paid purchase.
Negative
  • None.

Insights

TL;DR: Director received a small RSU grant vesting in one year, aligning compensation with shareholder incentives without immediate dilution.

The grant of 277 restricted stock units to a director is a routine equity-based compensation event intended to align long-term interests with shareholders. The units vest 100% on 09/01/2026, creating a one-year retention incentive. The acquisition reported at $0 indicates these are compensation units rather than a market purchase. For investors, this is a standard governance practice and not a material transaction for a company Ulta's size.

TL;DR: Transaction is immaterial to ULTA valuation; it's an ordinary director RSU grant with no immediate cash flow impact.

The Form 4 documents a non-derivative acquisition of 277 RSUs by a director, increasing her beneficial ownership to 277 shares post-transaction. The grant price of $0 and the one-year cliff vesting show standard equity compensation mechanics. There are no sales or option exercises disclosed, so there is no change in free float from exercised options in this filing. This item is informational for insider holdings tracking but not a material corporate action.

Stephanie Lee Landry, membro del consiglio di Ulta Beauty, Inc. (ULTA), ha acquisito 277 unità azionarie vincolate il 01/09/2025. Il Modulo 4 riporta la concessione come acquisizione (codice A) senza pagamento in contanti ($0). La dichiarazione indica la detenzione beneficiaria di 277 azioni a seguito della transazione in forma di proprietà diretta. Le RSU sono descritte nell’esplicazione come soggette a vesting al 100% il 01/09/2026. Il Modulo 4 è stato firmato da un procuratore il 03/09/2025. Non risultano derivati, esercizi di opzioni, acquisti in contanti o vendite in questa comunicazione.

Stephanie Lee Landry, directora de Ulta Beauty, Inc. (ULTA), adquirió 277 unidades restringidas de acciones el 01/09/2025. El Formulario 4 reporta la concesión como una adquisición (código A) sin pago en efectivo ($0). La presentación muestra 277 acciones en propiedad beneficiaria tras la transacción en forma de titularidad directa. Las RSU se describen en la explicación como sujetas a vesting al 100% el 01/09/2026. El Formulario 4 fue firmado por un apoderado el 03/09/2025. No se informan derivados, ejercicios de opciones, compras en efectivo ni ventas en esta presentación.

Ulta Beauty, Inc.(ULTA) 이사인 스테파니 리 랜드리(Stephanie Lee Landry)가 2025-09-01에 제한부주식단위(RSU) 277주를 취득했습니다. Form 4는 해당 부여를 현금 대가 없는 취득(코드 A)으로 보고하고 있습니다($0). 제출서류에는 거래 후 직접 소유 형태로 277주를 실질적으로 보유하고 있는 것으로 표시되어 있습니다. RSU는 설명란에 2026-09-01에 100% 베스팅된다고 기재되어 있습니다. Form 4는 2025-09-03에 대리인(변호사 대리인)에 의해 서명되었습니다. 이 제출에는 파생상품, 옵션 행사, 현금 매수 또는 매도는 보고되지 않았습니다.

Stephanie Lee Landry, administratrice d’Ulta Beauty, Inc. (ULTA), a acquis 277 unités d’actions restreintes le 01/09/2025. Le formulaire 4 signale la remise comme une acquisition (code A) sans contrepartie en espèces (0 $). Le dépôt indique 277 actions détenues bénéficiairement après la transaction sous une forme de propriété directe. Les RSU sont décrites dans l’explication comme vestant à 100 % le 01/09/2026. Le formulaire 4 a été signé par un mandataire le 03/09/2025. Aucun dérivé, exercice d’option, achat en espèces ou vente n’est déclaré dans ce dépôt.

Stephanie Lee Landry, Direktorin von Ulta Beauty, Inc. (ULTA), erwarb am 01.09.2025 277 Restricted Stock Units. Das Formular 4 meldet die Zuteilung als Erwerb (Code A) ohne Barzahlung ($0). Die Einreichung weist nach der Transaktion 277 wirtschaftlich gehaltene Aktien in direktem Eigentum aus. In der Erläuterung werden die RSUs mit vollständiger Vesting zum 01.09.2026 beschrieben. Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten unterzeichnet. In dieser Meldung sind keine Derivate, Optionsausübungen, Barkäufe oder Verkäufe angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Landry Stephenie Lee

(Last) (First) (Middle)
1000 REMINGTON BLVD

(Street)
BOLINGBROOK IL 60440

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/01/2025 A 277(1) A $0 277 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of 277 restricted stock units, vesting 100% on 9/1/2026.
s/ Rene G. Casares, as attorney-in-fact for Stephanie Lee Landry 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ulta Beauty director Stephanie Lee Landry report on Form 4 (ULTA)?

She reported a grant of 277 restricted stock units acquired on 09/01/2025 with 100% vesting on 09/01/2026.

Does the Form 4 show a sale or purchase of ULTA shares for cash?

No. The transaction code is A (acquisition) with a price of $0, indicating an RSU compensation grant rather than a cash purchase or sale.

How many shares does Stephanie Lee Landry beneficially own after this transaction?

277 shares are reported as beneficially owned following the reported transaction, in direct ownership form.

When do the restricted stock units reported on the Form 4 vest?

The RSUs vest 100% on 09/01/2026, per the explanation in the filing.

When was the Form 4 signed and filed?

The signature date shown is 09/03/2025 by an attorney-in-fact for Stephanie Lee Landry.
Ulta Beauty

NASDAQ:ULTA

ULTA Rankings

ULTA Latest News

ULTA Latest SEC Filings

ULTA Stock Data

23.74B
44.72M
0.26%
98.31%
4.24%
Specialty Retail
Retail-retail Stores, Nec
Link
United States
BOLINGBROOK